Latest News

Zolgensma Tumour Risk: Does the Gene Therapy Cause Tumours?

Zolgensma Tumour Risk: Does the Gene Therapy Cause Tumours?

Zolgensma tumour risk moved from a label warning to a reported safety signal on 5 November 2026. Novartis said it had received nine tumour reports in treated patients since the 2019 approval. In two cases, the company said, there is evidence that vector DNA integrated...

read more

Latest News

Surgical Site Infections Can Consume Up to 75 Staff Hours

Surgical Site Infections Can Consume Up to 75 Staff Hours

Surgical site infections can consume up to 75 staff hours and displace three operations, research finds A single surgical site infection (SSI) can consume an estimated 45 to 75 additional hours of healthcare staff time and create downstream demands equivalent to the...

read more

Join The Future Of Life Sciences Media

 

In a world overflowing with information, LifeScienceDaily.news stands apart as the dedicated space where life sciences professionals share what’s new, what’s next, and why it matters, all in real time.

 

 

Don’t wait for the media to pick up your story. Be the media.

More News

Report Finds Seven in Ten Leaders Bullied by Their Teams

Report Finds Seven in Ten Leaders Bullied by Their Teams

Healthcare organisations invest significantly in psychosocial risk frameworks, governance structures and leadership development. Yet a new international study highlights a type of organisational risk that most of those frameworks are not designed to detect. It is a...

read more
Trump FDA Drug Approvals: Global Impact

Trump FDA Drug Approvals: Global Impact

Trump FDA Drug Approvals: How US Regulatory Upheaval Is Reshaping the Global Pharmaceutical Industry The United States Food and Drug Administration has long been regarded as the gold standard of drug regulation. When a medicine receives FDA approval, it carries a...

read more
Most Supplement Companies Skip the RCT

Most Supplement Companies Skip the RCT

Most Supplement Companies Skip the RCT. Here’s Why the Few That Don’t Often Get It Wrong The industry’s uncomfortable truth The global dietary supplement market is worth hundreds of billions of dollars.[1] Brands make claims about energy, cognition, immunity, and...

read more
Physiology: The Missing Layer in Precision Medicine

Physiology: The Missing Layer in Precision Medicine

Precision medicine has been positioned as one of the most promising evolutions in modern healthcare. Gene panels. Liquid biopsies. Microbiome-targeted therapies. Multi-omics integration. The premise is compelling: the more precisely we can characterize biological...

read more
Weekly News Roundup | 27 April 2026

Weekly News Roundup | 27 April 2026

Life science news 27 April 2026: Eli Lilly's $7 billion in vivo CAR-T deal, Trump's psychedelics executive order and a first-ever gene therapy for hearing loss headline a landmark week across global life science. Eli Lilly announced on 20 April its acquisition of...

read more
Life Science Daily News: Join the Community

Life Science Daily News: Join the Community

A Community-Driven Hub for Life Sciences News and Discovery In an era of rapid scientific progress and near-constant breakthroughs, having a reliable, inclusive platform to share and explore life-sciences news is more important than ever. Life Science Daily News...

read more
Report Finds Seven in Ten Leaders Bullied by Their Teams

Report Finds Seven in Ten Leaders Bullied by Their Teams

Healthcare organisations invest significantly in psychosocial risk frameworks, governance structures and leadership development. Yet a new international study highlights a type of organisational risk that most of those frameworks are not designed to detect. It is a...

read more
Trump FDA Drug Approvals: Global Impact

Trump FDA Drug Approvals: Global Impact

Trump FDA Drug Approvals: How US Regulatory Upheaval Is Reshaping the Global Pharmaceutical Industry The United States Food and Drug Administration has long been regarded as the gold standard of drug regulation. When a medicine receives FDA approval, it carries a...

read more
Most Supplement Companies Skip the RCT

Most Supplement Companies Skip the RCT

Most Supplement Companies Skip the RCT. Here’s Why the Few That Don’t Often Get It Wrong The industry’s uncomfortable truth The global dietary supplement market is worth hundreds of billions of dollars.[1] Brands make claims about energy, cognition, immunity, and...

read more
Physiology: The Missing Layer in Precision Medicine

Physiology: The Missing Layer in Precision Medicine

Precision medicine has been positioned as one of the most promising evolutions in modern healthcare. Gene panels. Liquid biopsies. Microbiome-targeted therapies. Multi-omics integration. The premise is compelling: the more precisely we can characterize biological...

read more
Weekly News Roundup | 27 April 2026

Weekly News Roundup | 27 April 2026

Life science news 27 April 2026: Eli Lilly's $7 billion in vivo CAR-T deal, Trump's psychedelics executive order and a first-ever gene therapy for hearing loss headline a landmark week across global life science. Eli Lilly announced on 20 April its acquisition of...

read more
Life Science Daily News: Join the Community

Life Science Daily News: Join the Community

A Community-Driven Hub for Life Sciences News and Discovery In an era of rapid scientific progress and near-constant breakthroughs, having a reliable, inclusive platform to share and explore life-sciences news is more important than ever. Life Science Daily News...

read more

Featured Articles

DNA double helix beside a microscope, test tubes and a pipette over a petri dish, representing life science publishing

Life Science Publishing: Our First Year, and Where You Fit In

Almost a year ago, Life Science Daily News published its first articles with a simple belief. Specialist science deserves a specialist stage. Since then, that belief has grown into a global readership and an active community of contributors. This is the story of our...
FDA building exterior alongside pharmaceutical laboratory setting representing drug approval decisions

FDA Drug Approval Decisions

Last updated 28 October 2026. Covering target action dates from October 2026 to February 2027. October changed how this tracker has to be read. Six FDA drug approval decisions landed in the month, and four arrived ahead of target. One cleared roughly 12 weeks early,...
gloved hands holding a glowing blue sample vial (labelled LOT: 24-B1, SAMPLE: GENO-) with a lab researcher working in the background.

CRISPR Gene Editing 2026: Rare Diseases, Cancer and Autoimmune

CRISPR gene editing in 2026 is no longer a technology to watch. It is a technology delivering results. Across three distinct disease areas, rare inherited conditions, haematologic and solid cancers, and autoimmune disease, clinical programmes are accumulating...
Three GLP-1 drug pipeline injection pens and oral tablets beside a clinical trial efficacy chart on a clipboard

The GLP-1 Drug Pipeline: Every Candidate to Watch in 2026

The GLP-1 drug pipeline has become one of the most consequential and closely watched in modern pharmaceutical history. In 2026, the class of glucagon-like peptide-1 receptor agonists is no longer defined solely by Ozempic and Wegovy. A new generation of oral tablets,...
Sjögren's disease diagnosis: close-up of a dry, irritated eye with eye drops being applied

Anti-Ro52 vs Anti-Ro60: Advancing Sjögren’s Disease Diagnosis

Autoantibody testing is a central part of autoimmune disease diagnosis, including Sjögren’s disease (SjD). The American College of Rheumatology and European Alliance of Associations of Rheumatology (ACR/EULAR) classification criteria for SjD incorporate ocular and...

Further News

Clinical Trials Roundup | 24 April 2026

Clinical Trials Roundup | 24 April 2026

Neurona Therapeutics' rezanecel demonstrates durable seizure reduction past the one-year mark in drug-resistant mesial temporal lobe epilepsy at the AAN Annual Meeting, Gilead Sciences and Arcus Biosciences' TIGIT inhibitor domvanalimab fails its pivotal Phase 3 lung...

read more
When ADHD and Menopause Overlap

When ADHD and Menopause Overlap

When ADHD and Menopause Overlap: Why Midlife Women Are Still Not Getting the Right Answers Girls and women have historically been overlooked in the ADHD diagnostic process and this is due, in part, to the fact that their symptoms often present differently than they do...

read more
How Rapid Access MRI Can Reshape Diagnostic Pathways

How Rapid Access MRI Can Reshape Diagnostic Pathways

It’s no secret that the National Health Service (NHS) is suffering diagnostic pressure. The British Medical Association (BMA) reports that in November 2024, approximately 1.6 million people in England were waiting for a diagnostic test. That’s double the 0.8...

read more
Panthera Biopartners Expands European Footprint

Panthera Biopartners Expands European Footprint

Panthera Biopartners Expands European Footprint with Acquisition of Hungary’s Leading Clinical Research Organisation, OEC Strategic acquisition marks the first step in Panthera’s European expansion, strengthening its global competitiveness Panthera Biopartners...

read more
NHS England First in World to Offer Blenrep for Myeloma

NHS England First in World to Offer Blenrep for Myeloma

Blenrep Multiple Myeloma NHS England Rollout Makes UK a World First in Blood Cancer Treatment England has become the first country in the world to make GSK's belantamab mafodotin, marketed as Blenrep, available to multiple myeloma patients through a national health...

read more

Further News

The Next Era of Cardiorenal Care Is Precision Fluid Management

Medicine has become increasingly specialized over the past several decades, driving tremendous advances in our ability to diagnose and treat complex diseases. Specialists now possess deeper expertise than ever before, allowing clinicians to deliver highly targeted...

Clinical Trials Roundup | 21 Aug 2026

Merck and Moderna’s intismeran autogene meets its primary endpoint in the Phase 3 INTerpath-001 trial in completely resected melanoma, Ultragenyx’s Genglycos receives FDA accelerated approval as the first treatment for glycogen storage disease type Ia, argenx’s...

The Ketogenic Diet: Why Long-Term Safety Deserves Greater Scrutiny

The ketogenic diet has transitioned from a highly specialized therapeutic intervention to a widely promoted dietary strategy for weight loss, metabolic health, inflammation, and, in some circles, cancer prevention or treatment. Its popularity has outpaced the strength...

Human-in-the-Loop or Human-on-the-Loop? Pharma’s AI Authority Test

“But what can this AI model actually do?” It’s a common question being asked across the life sciences industry. Can it classify a symptom, summarize a trial record, predict a molecule’s behavior, or monitor a manufacturing process? Those capabilities matter, but they...

Physical Activity and Dementia: The Evidence Base Is Uneven

The link between physical activity and dementia depends on where that activity happens, according to a meta analysis of 74 studies covering more than four million adults. Leisure time exercise was associated with a lower risk of dementia, while activity undertaken at...

The Next Recruitment Challenge Isn’t Awareness, It’s Qualification

For years, the clinical research industry has focused heavily on one question: How do we reach more patients? Digital advertising, social media campaigns, patient advocacy partnerships, and online recruitment platforms have dramatically expanded researchers' ability...

From Digital Transformation to Operational Intelligence in Healthcare

Healthcare has never really had a technology problem. The greater challenge has been turning technology into better ways of working. Over the past decade, healthcare organizations have invested heavily in electronic health records, digital services, automation,...

Fatty Pancreas Disorder and the New Era of Integrated Obesity Management

Obesity is increasingly recognized as a chronic systemic disease characterized not only by excess adiposity but also by progressive dysfunction of multiple organs. Recent advances have shifted attention from body weight alone toward ectopic fat deposition as a major...

Rethinking Biomedical Research in the Age of AI

The paradox of modern biomedical research Biomedical research has never generated so much knowledge, and researchers have never struggled so much to keep pace with it. PubMed now indexes more than 40 million references drawn from roughly 26,000 journals[1]....

Australia Marks 40 years of Daffodil Day on Thursday 20 August

Cancer Council calls on Australians to help fund the next 40 years of breakthroughs One of Australia's most iconic and enduring fundraising campaigns, Daffodil Day, will return on Thursday 20 August 2026, marking 40 years of Australians coming together to support...

Retatrutide Black Market: Lilly Sues Six US Sellers

Eli Lilly has filed six lawsuits against United States companies. It accuses them of selling illegal versions of its experimental obesity drug, which remains in Phase 3 trials. The retatrutide black market runs through peptide websites, medical spas and wellness...

Modeling T Cell Dysfunction: New Frontiers in Immunometabolism

While cancer immunotherapies—particularly immune checkpoint blockades (ICBs)—have transformed clinical oncology, primary and acquired resistance remain major hurdles in solid tumors. Mounting evidence reveals that this non-responsiveness is deeply tied to the...

Want to Be Part of the Next Chapter in Life Sciences Media?

 

LifeScienceDaily.news is building a new kind of platform where innovators, researchers, and industry leaders tell their own stories and shape the narrative of what’s next in life sciences. Share your story and lead the conversation.

 

 

Don’t wait for the media to pick up your story. Be the media.

See More Articles

Want to Be Part of the Next Chapter in Life Sciences Media?

 

LifeScienceDaily.news is building a new kind of platform where innovators, researchers, and industry leaders tell their own stories and shape the narrative of what’s next in life sciences. Share your story and lead the conversation.

 

 

Don’t wait for the media to pick up your story. Be the media.